$3.25
-0.42-11.44%
At close: -
$3.14
-0.11-3.53%
After Hours: 7:43 PM EDT
Comments
Loading...
BriaCell Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BCTX | Benzinga
BriaCell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 16
EPS
$-3.300
Quarterly Revenue
$0.00
Annual Revenue
(as of Oct 31)
(as of Oct 31)
–
Analyze the earnings history of BriaCell Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
BriaCell Therapeutics (BCTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-12-16 | $-3.30 | $-4.50 | 26.7 % |
| Q4 | 2024-10-29 | $-1.05 | $-7.80 | 86.5 % |
| Q3 | 2024-06-14 | $1.65 | $-8.25 | 120.0 % |
| Q2 | 2024-03-18 | $-10.65 | $-3.00 | -255.0 % |
BriaCell Therapeutics (BCTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?
BriaCell Therapeutics (BCTX) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on December 16, 2024 for Q1.
What were the latest earnings per share (EPS) for BriaCell Therapeutics (NASDAQ:BCTX)?
The Actual EPS was $-3.30, which beat the estimate of $-4.50.
What were BriaCell Therapeutics’s (NASDAQ:BCTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.